O8Z3 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sonoma Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 2.72 EUR Market Closed

Market Cap: €51.7m

S	Sonoma Pharmaceuticals Inc F:O8Z3	US
	Pyrum Innovations AG F:PYR	DE
	Bendigo and Adelaide Bank Ltd ASX:BEN	AU

Profitability Summary

Sonoma Pharmaceuticals Inc's profitability score is 17/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

38%

Sustainable 3Y Average Gross Margin

37%

Gross Margin is Increasing

35% > 38%

Negative Operating Margin

-16%

Negative 3Y Average Operating Margin

-30%

Operating Margin is Increasing

-37% > -16%

Negative Net Margin

-19%

Negative 3Y Average Net Margin

-32%

Net Margin is Increasing

-45% > -19%

Negative Free Cash Flow Margin

-21%

Negative 3Y Average Free Cash Flow Margin

-20%

Free Cash Flow Margin is Increasing

-40% > -21%

Negative ROE

-81%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-42%

ROIC is Increasing

-45% > -33%

View All

Hide

Collapse

17 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.